From a suite of swank, sun-drenched offices above an art gallery in Studio Park, hedge fund manager Eiad Asbahi has been waging a proxy war for control of a little-known pharmaceutical company, whose stock is in the tank. The Georgia-based company, MiMedx, specializes in tissue grafts that have proven highly effective in wound care. Despite
Don’t sell Eiad Asbahi short
Sign up for the free Daily Report email – local news about the people, companies and issues that impact business impact business in Baton Rouge and beyond.
